MedTrace Logo

Effect of Pentoxifylline on Endothelial Dysfunction in Patients With Acute Coronary Syndrome

NCT04367935 · Status: COMPLETED · Phase: PHASE2/PHASE3 · Type: INTERVENTIONAL · Enrollment: 43

Last updated 2022-09-07

No results posted yet for this study

Summary

This study aims to investigate the effect of pentoxifylline administration on the status of endothelial function and oxidative stress biomarkers in patients with Acute Coronary Syndrome (ACS).

Conditions

  • Acute Coronary Syndrome

Interventions

DRUG

Pentoxifylline

Pentoxifylline tablets 400mg three times daily for 2 months

Sponsors & Collaborators

  • Ain Shams University

    lead OTHER

Principal Investigators

  • Asmaa Saeed, Bachelor · Teaching Assistant at the Faculty of Pharmacy, Ain Shams University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-01-01
Primary Completion
2022-04-25
Completion
2022-04-25

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04367935 on ClinicalTrials.gov